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Ngn1 is a basic helix-loop-helix (bHLH) transcription factor expressed in specific regions within the developing brain and spinal cord,
sensory ganglia, and olfactory epithelium. We have identified sequences both 5V and 3V of the mouse ngn1 gene that function in regulating
ngn1 expression, and each of these sequences contains distinct regulatory cassettes for different subregions of the expression domain.
Enhancers for expression in ngn1 domains of the midbrain, hindbrain, trigeminal ganglia, and ventral–neural tube appear redundant and are
spread both 5V and 3V of the ngn1 coding sequence. In contrast, a single discrete dorsal–neural tube enhancer was located in the 5V sequence
that is conserved among mouse, human, chick, and zebrafish ngn1 genes. Functionally, this enhancer is both necessary and sufficient for
driving expression of a heterologous reporter in transgenic mice specifically to the dorsal domain of ngn1 expression in the spinal neural tube.
Thus, sequences are identified that can be used to direct temporally and spatially restricted expression of heterologous genes to the
developing neural tube.
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Spinal cord developmentIntroduction
Neural-expressed basic helix-loop-helix (bHLH) tran-
scription factors are essential for the formation of the
nervous system from worms to mammals. A subset of
neural bHLH factors is transiently expressed during nervous
system development in proliferating neural progenitor cells
as they transition to differentiated neurons (Lee, 1997). This
subset includes neurogenin 1 (Ngn1), neurogenin 2 (Ngn2),
Mash1, and Math1. Each of these bHLH factors has a
unique expression pattern within the developing nervous
system, and loss-of-function studies in mouse have demon-
strated their importance in the formation of specific pop-
ulations of neurons (Bertrand et al., 2002). Thus, each of
these regulatory proteins must be expressed at the right time
and at the right place for a viable nervous system to form. In0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.04.021
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expression of one of these factors, Ngn1, is regulated.
Ngn1 is expressed during embryogenesis in the cranial
and spinal sensory ganglia, in specific dorsal and ventral
regions of the spinal neural tube, the dorsal telencephalon,
specific regions within the midbrain and hindbrain, and
the olfactory epithelium (Cau et al., 2002; Lee, 1997; Ma
et al., 1996, 1997; Sommer et al., 1996). In general,
expression is seen in proliferating progenitor cells during
the initiation of neuronal differentiation. Loss-of-function
studies in mouse have shown that Ngn1 is required for the
formation of proximal cranial sensory ganglia and olfac-
tory neurons (Cau et al., 2002; Ma et al., 1998, 1999). In
combination with the related factor Ngn2, Ngn1 is re-
quired for the normal formation of the dorsal root ganglia,
the dorsal interneuron population dI2, and cerebral cortex
(Gowan et al., 2001; Ma et al., 1999; Nieto et al., 2001).
Overexpression of Ngn1 in multiple systems has also
yielded insights into Ngn1 function. Ngn1 induces neuro-
nal differentiation in cortical progenitor cells (Sun et al.,
2001), in P19 embryonal carcinoma cells (Farah et al.,
2000), in the chick neural tube (Gowan et al., 2001), in
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1997). Ngn1 not only functions to induce neuronal differ-
entiation but also to specify neuronal subtype in the
peripheral nervous system and the dorsal–neural tube
(Gowan et al., 2001; Perez et al., 1999). Thus, under-
standing how the expression of ngn1 and related genes is
regulated has critical implications in defining the molec-
ular mechanisms involved in generating a nervous system
with the correct number and correct types of neurons.
The transcriptional regulation of neural bHLH factor
genes has been studied using transgenic mice to identify
cis regulatory sequences. For ngn1, a 7.5-kb sequence 4 kb
5V of the transcription start was shown to direct reporter
gene expression to a subset of the ngn1 expression domains
in the central nervous system, the trigeminal ganglia, and
olfactory epithelium (Gowan et al., 2001). Two sequences
within this 7.5 kb are conserved with sequence flanking the
zebrafish ngn1 gene and were shown in zebrafish to be
required for expression in lateral stripe and the anterior
neural plate (Blader et al., 2003). In contrast, an enhancer
for Mash1 was identified over 7 kb 5V of the Mash1 coding
region that is sufficient to direct expression to a subset of
Mash1 expression domains in the central nervous system
(Verma-Kurvari et al., 1998). For Math1, an enhancer was
identified 3 kb 3V of the coding sequence that is sufficient to
direct expression to all Math1 expression domains (Ebert et
al., 2003; Helms et al., 2000). And finally, similar to ngn1,
the ngn2 gene has regulatory elements spread over 20 kb of
sequence, with distinct regulatory sequences directing ex-
pression to different subsets of the ngn2 expression pattern
(Scardigli et al., 2001; Simmons et al., 2001). Except for
some conserved sequences in the 3V end of ngn2 and ngn1
that were shown to direct expression to the neural tube
(Simmons et al., 2001), no common mechanisms for
regulating the bHLH genes have been reported. Even
autoregulation properties are distinct. Mash1 is involved
in a negative autoregulatory loop (Horton et al., 1999;
Meredith and Johnson, 2000); Math1, like its Drosophila
homolog atonal, activates expression from its own enhanc-
er (Ebert et al., 2003; Helms et al., 2000; Sun et al., 1998);
and the ngn genes do not seem to autoregulate at all (JEJ,
unpublished data). The direct upstream transcriptional reg-
ulators of these bHLH genes are largely undefined. How-
ever, Pax6, a paired homeodomain transcription factor, has
been shown to regulate ngn2 expression (Scardigli et al.,
2001, 2003); and Zic1, a Zn finger transcription factor, has
been shown to regulate Math1 expression (Ebert et al.,
2003).
Given the temporal and spatial characteristics of ngn1
expression and its known functions in neurogenesis and
neuronal cell-type specification, it is likely that the regu-
latory sequences controlling ngn1 expression are integrat-
ing patterning and differentiation signals. To begin to
understand the control of these processes, we have iden-
tified sequences within the ngn1 gene that regulate its
expression. Distinct sequences 5V and 3V of the gene directexpression to subregions of the hindbrain, midbrain, and
spinal neural tube, the trigeminal ganglia, and the olfactory
epithelium. A dorsal–neural tube enhancer was defined
within a 830-bp sequence that is both necessary and
sufficient for restricted expression in the dorsal–neural
tube, and this sequence is conserved among human,
mouse, chick, and fish. This enhancer sequence will serve
as a tool for directing tissue-specific expression and as a
tool for identifying the factors that bind it to regulate ngn1
expression in this specific domain within the dorsal–neural
tube.Materials and methods
Generation of transgenic constructs
A lambda clone from a Stratagene 129SV mouse ge-
nomic library, containing approximately 11 kb of sequence
5V to the ngn1 coding region and 3 kb 3V sequence, was
provided by Q. Ma and D. Anderson. TgN1-1, TgN1-2, and
TgN1-2G were described previously (Gowan et al., 2001).
The BGZA plasmid was used for all lacZ reporter trans-
genes and contains the h-globin basal promoter, lacZ coding
region, and SV40 polyadenylation sequences (Yee and
Rigby, 1993). The GFP reporter transgenes were generated
from BG-EGFP, which replaces the lacZ reporter and SV40
polyA of BGZA with the EGFP coding region and bovine
growth hormone polyadenylation signal from pIRES-EGFP
(Clontech) (Gowan et al., 2001). TgN1-1 to TgN1-7, TgN1-
9 to TgN1-11, and TgN1-13G were generated using avail-
able restriction enzymes, which are shown in Figs. 1 and 2.
TgN1-2GD13 is TgN1-2G with the dorsal–neural tube
enhancer deleted by deleting the 860 bp between restriction
enzymes BclI and HpaI. TgN1-8 and its derivatives were
generated by PCR, sequence verified, and diagrammed in
Fig. 4. The end primers used were 5VGAA GAT CTA CAG
GAG TGG AAC AAG GT 3V and 5VGCT CTA GAC AAC
TGC TGC GGT GGT TTG 3V. The specific sequences
mutated in TgN1-8mB1 through TgN1-8mB6 are indicated
in Fig. 3B. Specific details for constructing the transgenes
are available upon request. Transgene fragments were iso-
lated from vector sequences and prepared for injection as
previously described (Helms and Johnson, 1998).
Transgenic mouse generation and analysis
Transgenic mice were generated by standard procedures
(Hogan et al., 1986) using fertilized eggs from B6D2F1
(C57B1/6  DBA) crosses. Transgene expression was
assayed in either founder embryos (G0) or embryos
obtained from established transgenic lines (G1) outbred
with B6D2F1. Embryos were staged based on assumed
copulation at E0, halfway through the dark cycle. Trans-
genic animals were identified by PCR analysis using tail
or yolk sac DNA. The lacZ reporter was detected as a
Fig. 1. Distinct regulatory sequences identified in the ngn1 gene. (A) Schematic illustrating the lacZ transgenes TgN1-1 to TgN-11 tested in transgenic mouse
embryos. The black line at the top represents the ngn1 gene with the coding sequence represented by the solid black box. Numbers in parentheses refer to the
number of nucleotides 5V (negative numbers) or 3V (positive numbers) of the ATG of ngn1, which is set to 1. #TgM is the number of independently derived
transgenic embryos examined, and #expressing is the number of embryos expressing the lacZ transgene in the tissues indicated. DRG is dorsal root ganglia.
(B–H) Representative E11.5 cleared whole-mount X-gal-stained embryos containing the specified transgene. Arrows indicate expression in the trigeminal
ganglia (B and G) or the lack of trigeminal ganglia expression (C). Arrowheads indicate hindbrain expression (D) or the lack of hindbrain expression (E and F),
and asterisks indicate midbrain expression (E) or the lack of midbrain expression (D and F). (I –K) Cross sections through the spinal cord of transgenic
embryos. Arrows indicate the intermediate neural tube expression and the arrowheads indicate the dorsal–neural tube expression. Asterisks indicate the floor
plate.
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GAT GTA 3V and 5V TGC TGC TGG TGT TTT GCT TCC
3V. The GFP reporter was detected as a 320-bp product
using primers 5V CTG ACC CTG AAG TTC ATC TGC
ACC 3V and 5V TGG CTG TTG TAG TTG TAC TCC
AGC 3V.
Staged embryos containing transgenes were dissected
in cold PBS. Transgenic embryos with GFP were visual-
ized and imaged immediately then fixed and processed as
described below for sectioning. LacZ transgenic embryos
were fixed for 30 min in 4% formaldehyde pH 7.2 at
room temperature, and whole-mount h-gal staining was
carried out as described (Verma-Kurvari et al., 1996).
Embryos were cleared with methyl salicylate for imaging.
All embryos collected for thin section analysis weredissected in cold PBS, fixed in cold 4% formaldehyde
pH 7.2 for 2 h, rinsed in cold PBS 2–4 h, sunk in 30%
sucrose in PBS overnight at 4jC, embedded in OCT, and
cryosectioned at 30 Am. All sections shown are from the
upper limb level.
Position effects on transgene expression are commonly
seen in transgenic experiments, particularly when small
regulatory elements are being tested. To control for this
variability, multiple independently derived transgenic em-
bryos were analyzed for each construct. The number of
embryos analyzed in each case is noted in the figures
(#TgM). Although it is difficult to make strong conclusions
from variations in expression levels due to the position
effects, in experiments in Fig. 4, when embryos consistently
expressed higher or lower levels of lacZ, relative to the
Fig. 2. The dorsal–neural tube enhancer is necessary and sufficient for tissue-specific expression. (A) Schematic illustrating the GFP reporter transgenes used.
The black line at the top represents the ngn1 5V sequence from (11035) to (3535). Numbers in parentheses refer to the number of nucleotides 5Vof the ATG
of ngn1, which is set to 1. #TgM is the number of independently derived transgenic embryos examined, and #expressing is the number of embryos expressing
the GFP transgene in the tissues indicated. (B) mRNA in situ hybridization with ngn1 probe demonstrating the endogenous expression pattern in a cross section
of the spinal neural tube at E11.5. (C, E, and G) Representative whole-mount GFP images of E11.5 transgenic embryos with the specified transgene. (D, F, and
H) Cross sections of the neural tube of E11.5 embryos with the indicated transgenes showing the dorsal and ventral domains of ngn1 expression. Abbreviations:
dnt, dorsal–neural tube; hb, hindbrain; mb, midbrain; oe, olfactory epithelium; tg, trigeminal ganglia; vnt, ventral–neural tube.
Y. Nakada et al. / Developmental Biology 271 (2004) 479–487482parental TgN1-8, it is noted and the possible significance
discussed.
mRNA in situ hybridization
mRNA in situ hybridization was performed essentially as
described (Birren et al., 1993) using 30 Am cryosections or
as whole embryos. Mouse ngn1 antisense probe was made
from a plasmid containing the whole coding region of
mouse ngn1.
Sequence for human, mouse, chick, and zebrafish ngn1
Human and mouse ngn1 sequence was obtained from the
public database. The chick ngn1 sequence was generated
from a clone isolated from a chick genomic library
(AY518341). Drs. P. Blader and U. Stra¨hle kindly provided
the zebrafish ngn1 sequence before submitting to GenBank
(AF017301).Results and discussion
Distinct regulatory sequences identified in the ngn1 gene
We have used transgenic mice to identify regulatory
sequences in the ngn1 gene. Previously, we reported that a
7.5-kb sequence found approximately 4 kb 5V of the ngn1
coding region was sufficient to direct expression of reporter
genes to multiple domains of the ngn1 expression pattern
including dorsal– and ventral–neural tube, midbrain, hind-
brain, sensory trigeminal ganglia, and the olfactory epithe-
lium (Gowan et al., 2001) (Fig. 1A; TgN1-2). A more
proximal 4 kb sequence did not have efficient, reliable
enhancer activity in this assay (Gowan et al., 2001; Murray
et al., 2000) (Fig. 1A; TgN1-1). We have extended these
previous studies by delineating three tissue-specific
enhancers within the 7.5-kb 5V regulatory regions and by
identifying additional regulatory sequences 3V of the coding
region.
Fig. 3. Sequence of the dorsal–neural tube enhancer of ngn1 is conserved between multiple species. (A) Diagram representing the regions of the ngn1 dorsal–
neural tube enhancer conserved between mouse, human, chicken, and zebrafish, the size of the conserved sequence, and the percent homology to the mouse
sequence. The zebrafish homology region was separated into three regions termed A, B, and C. Numbers in parentheses refer to nucleotide position in the
mouse ngn1 gene. (B) the sequence of homology region B is shown. Sequences in red indicate sequences identical between fish and mouse, the nucleotides in
black indicate mouse sequence not conserved with fish. The positions of the mutations mB1-mB6 that were tested in Fig. 4 are overlined.
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reporter constructs in transgenic mice (Fig. 1A; TgN1-3 to
TgN1-8), and three tissue-specific enhancers directing ex-
pression either to the midbrain, hindbrain, or dorsal–neural
tube were identified. Except for expression in the trigeminal
ganglia, TgN1-4 (4.5 kb) recapitulated expression seen with
TgN1-2 (7.5 kb) (Figs. 1A–C, arrow). Expression of the
reporter gene in the hindbrain in TgN1-5 but not TgN1-1 or
TgN1-6 demonstrates the presence of a hindbrain enhancer
between5536 and4034 (Figs. 1A, D, and E, arrowhead).
Expression of the reporter gene in the midbrain in TgN1-6
and TgN1-7, but not TgN1-8, reveals the presence of a
midbrain enhancer between 8054 and 7267 (Figs. 1A, E,
and F, asterisk). This mouse midbrain enhancer has sequence
conservation to the zebrafish anterior neural plate enhancer
recently identified (Blader et al., 2003). And finally, TgN1-6
and 8 demonstrate the presence of an enhancer sufficient to
direct dorsal–neural tube expression between 7267 and
5536 (Figs. 1A, E, and F). Sequence within the mouse
dorsal–neural tube enhancer is also conserved with the
identified zebrafish ngn1 enhancer (Blader et al., 2003).
Thus, three separable tissue-specific regulatory elements
are located within the 5V enhancer.
Regulatory sequences located 3V of the ngn1 coding
region were identified as well. A 3.1-kb 3V sequence includ-
ing part of the coding region drives expression of a lacZ
reporter in transgenic mice to domains within the midbrain,
hindbrain, intermediate neural tube, and the sensory trigem-
inal ganglia (Figs. 1A and G, TgN1-9). Two distinct tissue-
specific enhancers are located within this sequence. TgN1-
10 directs expression to the hindbrain and intermediate
neural tube (Figs. 1A, H, and K), and TgN1-11 directsexpression to the midbrain (Fig. 1A). Previously, an approx-
imately 275-bp sequence within TgN1-10 was shown to
have conservation with the 3V end of the ngn2 gene, and
when multimerized, directed expression to the hindbrain and
intermediate neural tube (Simmons et al., 2001). This sug-
gests the importance of the approximately 275-bp ngn2
homology for activity of the TgN1-10 enhancer.
Two domains of ngn1 expression seem to be controlled
by sequences spanning large regions 5V and 3V of the ngn1
coding sequence. Information for trigeminal ganglia expres-
sion is located both 5V (TgN1-2) and 3V (TgN1-9) of the gene
(Figs. 1A, B, and G). We could not localize the 5V trigeminal
ganglia element within the 5V enhancer, as no subfragment of
N1-2 was sufficient to drive expression in this tissue (Fig.
1A; TgN1-3 and 4). Likewise, the elements sufficient to
direct expression to the intermediate neural tube are found
both 5V and 3V to the gene (Fig. 1A). Each fragment tested
from the 5V and 3V enhancers contains some level of activity
in the intermediate neural tube except TgN1-11 (Figs. 1A, I,
J, and K, arrows). Taken together, these data demonstrate
that information for directing expression of ngn1 to multiple
domains is distributed both 5V and 3V of the ngn1 coding
region and some of this information appears to be encoded
redundantly.
The 14 kb sequence tested does not efficiently function
in driving expression to two major ngn1 expression
domains, the dorsal root ganglia and the dorsal telenceph-
alon. This suggests that sequences outside this 14 kb are
required for efficient expression in these domains. However,
the contiguous 14-kb sequence was not tested in a single
transgene; thus, it is possible that these expression patterns
require synergistic interactions between 5V and 3V sequences.
Fig. 4. Distinct sequences within the dorsal–neural tube enhancer of ngn1 are required for enhancer activity. (A) Schematic illustrating the transgenes tested in
transgenic mice. All transgenes are based on TgN1-8 (see Fig. 1A). #TgM is the number of independently derived transgenic embryos examined, and
#expressing is the number of embryos expressing the lacZ transgene specifically in the dorsal–neural tube. Red dots indicate the approximate position of the
mutation within the transgene, and the specific mutated sequence is indicated in Fig. 3B. (B–F and H–J) Representative whole-mount X-gal-stained E11.5
embryos with the indicated transgene. Arrow in C–E indicates the restricted rostral/caudal regions expressing the transgene. (G) Cross section of an embryo
containing TgN1-8Bx4 showing the predicted dorsal–neural tube (dnt) expression as well as the unexpected dorsal root ganglia (DRG) and sympathetic
ganglia (sym).
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dorsal–neural tube enhancer was sufficient to direct expres-
sion to the dorsal root ganglia (Figs. 4A and G; TgN1-
8Bx4). Thus, regulatory sequences within the 14-kb se-
quence tested either combine with each other or with
elements located more distal to ngn1 to completely recapit-
ulate the ngn1 expression pattern.The dorsal–neural tube enhancer
Because of our interest in the development of the dorsal
spinal cord, we chose to examine the dorsal–neural tube
enhancer in greater detail. Using transgenes with GFP as
reporter clearly demonstrates the activity of the 5V 7.5-kb
enhancer in both the dorsal and ventral domains of ngn1
Y. Nakada et al. / Developmental Biology 271 (2004) 479–487 485expression in the spinal neural tube (Fig. 2A; compare
endogenous ngn1 expression in Fig. 2B with TgN1-2G in
Figs. 2C and D). An 822-bp sequence (within TgN1-8)
located approximately 6 kb 5V the ngn1 coding region was
sufficient for driving efficient specific ngn1-like expression
in the dorsal–neural tube (Figs. 2A, E, and F; TgN1-13G).
Expression in the ventral–neural tube was lost except for
inefficient expression in the intermediate domain that was
seen with TgN1-8 (Fig. 1J). Furthermore, when this se-
quence was specifically deleted from TgN1-2G, only the
dorsal–neural tube expression was lost. The expression in
the ventral–neural tube, midbrain, hindbrain, olfactory
epithelium, and trigeminal ganglia was unaffected (Figs.
2A, G, and H; TgN1-2GD13). Thus, this approximately 0.8-
kb element is both necessary and sufficient for dorsal–
neural tube expression.
The dorsal–neural tube enhancer sequence is conserved
among mouse, human, chick, and zebrafish, consistent with
its importance in regulation of ngn1 expression. Comparison
of mouse sequence of the dorsal–neural tube enhancer (822
bp) to human and chick genomic sequences revealed a high
level of conservation. Mouse and human are 89% identical
over 680 bp, and mouse and chick are 88% identical over
530 bp (Fig. 3A). Furthermore, this same region conserved
among mouse, human, and chick also has significant ho-
mology to zebrafish ngn1 genomic sequence. We tested
three fragments from this homology region, which we call
region A, B, and C. The most conserved of these is region
B, which is 70% identical to mouse over 176 bp (Figs. 3A
and B). Deletion of each region, A, B, or C from TgN1-8,
resulted in dramatic but not complete loss of enhancer
activity (Figs. 4A, C–E). Interestingly, region A was re-
quired for the more caudal expression (Fig. 4C), and regions
B and C were required for rostral and extreme caudal
domains (Figs. 4D and E). The overall efficiency of obtain-
ing transgenic embryos that expressed at all with these
deletion mutants was significantly lower than that seen with
the wild-type enhancer (1 of 6, DB; 3 of 13, DC; compared
to 4 of 8, wild type). Loss of both region A and region C
resulted in a complete loss of enhancer activity (Fig. 4A;
TgN1-8DAC). Together, these data demonstrate the impor-
tance of this approximately 0.5 kb sequence for dorsal–
neural tube expression along the entire rostral/caudal axis of
the developing spinal cord.
Multimerized region B, the region with the highest
homology to zebrafish, was sufficient to drive expression
to the dorsal–neural tube; however, strong expression in
two unexpected tissues was also detected, the dorsal root
ganglia and sympathetic ganglia (Figs. 4A, F, and G). These
sensory and autonomic neuronal cells are neural crest
derived. Dorsal root ganglia normally express ngn1, but
we have never located a regulatory element that can drive
expression to this tissue. Sympathetic ganglia are not known
to express ngn1 but rather express a related bHLH factor
Mash1. Thus, region B, which is conserved from human to
fish, has positive elements for expression in the dorsal–neural tube and these two neural crest lineages, but expres-
sion in sympathetic ganglia at least must be silenced by
elements outside this sequence.
Mutations were made across the most highly conserved
regions of B to identify more discrete sequence elements
important for the activity of the dorsal–neural tube enhanc-
er. The specific sequences mutated in mB1–mB6 are shown
in Fig. 3B and diagrammed in Fig. 4A. In each case, the
mutations were random replacement of nucleotides designed
to maintain spacing requirements if any in the regulatory
element. Each construct was tested in E11.5 transgenic
embryos. No mutation completely eliminated activity of
the dorsal–neural tube enhancer (Fig. 4A). However, muta-
tions mB1 and mB2 consistently showed low enhancer
activity, particularly in caudal regions (Figs. 4A, H, and
I), resembling that seen with N1-8DA that deleted the
sequence 5V to mB1, suggesting these mutations may disrupt
binding of the same transcription complex. In contrast,
mutation mB4 resulted in an increased activity of the
enhancer, suggesting a loss of an inhibitory sequence.
Together these data suggest possible redundancy of tran-
scription factor binding sites within region B, and the
possibility that both activators and repressors bind at this
regulatory sequence to control ngn1 expression in the
dorsal–neural tube.Conclusion
There are multiple tissue-specific enhancers spanning
both 5V and 3V of the ngn1 gene. This configuration is similar
to cis-elements identified for ngn2 (Scardigli et al., 2001;
Simmons et al., 2001) but is in contrast to regulation of
Math1 where the identified enhancer directs expression to
all Math1 domains, and so far specific tissue elements have
not been separable (Helms et al., 2000). It is possible that
ngn1 and ngn2 may have conserved regulatory sequences
since these genes likely arose from gene duplication. So far,
one conserved element 3V between ngn1 and ngn2 has been
identified. Although the enhancer activities of these ele-
ments are not identical, both direct neural-specific expres-
sion (Simmons et al., 2001).
Computational analysis using the TRANSFAC database
for transcription factor binding sites within the fish homol-
ogy region of the ngn1 enhancer was performed (using
TESS from U. Pennsylvania; http://www.cbil.upenn.edu).
This analysis identified consensus binding sites for multiple
transcription factors. For example, consistent with the AT
rich nature of the enhancer (see Fig. 3), Cdx and Hox
homeodomain factors that function in rostral/caudal pattern-
ing were identified (Krumlauf, 1994; van den Akker et al.,
2002). Their possible role in regulating the ngn1 enhancer is
consistent with the fact that the different mutations resulted
in a loss of enhancer activity at different rostral/caudal
regions (Figs. 4C–E). The presence of multiple sites may
explain why enhancer activity was only dramatically affect-
Fig. 5. Summary diagram of the tissue-specific enhancers within the ngn1
gene. The black line indicates the mouse ngn1 gene and the open box
indicates the coding sequence. Specific restriction enzyme sites are
indicated for reference. Yellow ovals indicate sequence with homology to
zebrafish sequence (Blader et al., 2003). The blue line indicates broad
regulatory sequences containing information for expression in the
trigeminal ganglia (tg), and the green line indicates those for expression
in the ventral and/or intermediate neural tube (vnt). More distinct regulatory
regions have been identified for expression in the midbrain (mb; red boxes),
dorsal–neural tube (dnt; green box), and hindbrain (hb; blue boxes). Note,
the 4-kb proximal 5V sequence is inefficient in directing ngn1-specific
expression in transgenic mice (Gowan et al., 2001; Murray et al., 2000).
Y. Nakada et al. / Developmental Biology 271 (2004) 479–487486ed with larger mutations, but not when smaller mutations in
fish homology B were tested.
A focused analysis of transcription factor binding sites
over sequences mB1, mB2, and mB4 that disrupted enhanc-
er activity was performed. Mutation at the mB4 site resulted
in a consistent increase in enhancer activity, suggesting that
a transcriptional repressor binds this site. Two candidates,
Gtx and MEF2, were identified that could serve a repressor
function. Gtx is a homeodomain containing factor identified
as a transcriptional repressor that is expressed specifically in
glial cells of the brain (Awatramani et al., 2000; Komuro et
al., 1993). Expression at early stages of neural tube devel-
opment has not been described. MEF2 transcription factors
are expressed in the developing nervous system (Lyons et
al., 1995), and although these factors were originally iden-
tified as transcriptional activators (Gossett et al., 1989), they
have been shown to interact with cofactors that alter their
activity to repression (Sparrow et al., 1999). In contrast,
mutations in the mB1 and mB2 sites had an apparent
decrease in enhancer activity. The TRANSFAC analysis
revealed the possibility that this sequence is bound by a
complex containing LEF1, myb, and pax factors. An acti-
vator complex containing these components has been char-
acterized in the development of B cells (Jin et al., 2002).
The in vivo relevance of these transcription factors to the
regulation of ngn1 expression in nervous system develop-
ment will need to be directly demonstrated.
In conclusion, tissue-specific enhancers are redundantly
encoded and reside both 5V and 3V of the ngn1 coding region
(see diagram in Fig. 5). Enhancers directing expression to
the trigeminal ganglia, ventral or intermediate neural tube,
midbrain, and hindbrain seem to be repeated throughout the
14 kb of flanking sequence tested. However, to obtain ngn1
expression both in its dorsal and its ventral domains in the
spinal neural tube, distinct regulatory elements are required.
These enhancers likely respond uniquely to dorsal pattern-ing signals such as BMPs, or to ventral patterning signals
such as Shh. The identification of transcription factor
complexes that interact specifically with these cis-acting
regulatory sequences will be important for understanding
the molecular control of neuronal differentiation.Acknowledgments
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